<?xml version="1.0" encoding="utf-8"?>
<DATASETS>
	<DATASET xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" alias="MALY-DE_PCAWG_WGS_BWA" center_name="ICGC" broker_name="EGA" accession="EGAD00001002123">
		<TITLE>ICGC PCAWG Dataset: MALY-DE_PCAWG_WGS_BWA</TITLE>
		<DESCRIPTION>ICGC PCAWG Dataset for WGS BAM aligned using BWA MEM. Project: MALY-DE.</DESCRIPTION>
		<ANALYSIS_REF accession="EGAZ00001224745"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224744"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223045"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223029"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222980"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224724"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224702"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224706"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222947"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224728"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223051"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223055"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224732"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223018"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222959"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223069"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223019"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222933"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223043"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224750"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223060"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223024"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222954"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222946"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222949"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222975"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224746"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224741"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224717"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223046"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223050"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223035"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222990"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222969"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223039"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224725"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222978"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222986"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223010"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224704"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224734"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224729"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223065"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223072"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224719"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223023"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223021"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222944"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223005"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223020"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224727"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223068"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222936"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222953"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222958"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222999"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223003"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223034"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223067"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222940"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223030"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223009"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223071"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223015"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222977"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224739"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223041"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224705"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223031"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224736"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223064"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222988"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224711"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222934"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222997"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222973"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223026"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224755"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224753"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222965"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223038"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222957"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223078"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223032"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222943"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224737"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222935"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223037"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224748"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224752"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223077"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223008"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224738"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224714"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223058"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222952"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223033"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224715"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222950"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224726"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222991"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223049"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223056"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223022"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222961"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223012"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224730"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222974"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223052"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223074"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224722"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222951"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222996"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222987"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222993"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222989"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222994"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224751"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223059"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224754"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224740"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223011"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222941"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222948"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222972"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222985"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222968"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222982"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223017"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222964"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223040"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223044"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222962"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223002"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222981"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223000"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223016"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224712"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223054"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224731"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223006"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224733"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222945"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223042"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222971"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224709"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223027"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222992"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222998"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224703"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224742"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223001"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223057"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224723"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223036"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223063"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223061"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223073"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223048"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222939"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224756"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223062"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223025"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224710"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223066"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223053"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224743"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222932"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222976"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222963"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223075"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222984"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224716"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224735"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222966"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224707"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222942"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222955"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224747"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223070"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222970"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222995"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224713"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223028"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224720"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222937"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224718"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223014"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224708"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224721"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222938"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223013"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222983"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222960"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222967"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222979"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223007"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223076"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223047"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001222956"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223004"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224749"></ANALYSIS_REF>
		<POLICY_REF accession="EGAP00001000011" refname="ICGC Data Access Agreements" refcenter="ICGC">
			<IDENTIFIERS>
				<PRIMARY_ID>EGAP00001000011</PRIMARY_ID>
				<SUBMITTER_ID namespace="ICGC">ICGC Data Access Agreements</SUBMITTER_ID>
			</IDENTIFIERS>
		</POLICY_REF>
		<DATASET_LINKS>
			<DATASET_LINK>
				<URL_LINK>
					<LABEL>ICGC Data Portal</LABEL>
					<URL>http://dcc.icgc.org</URL>
				</URL_LINK>
			</DATASET_LINK>
		</DATASET_LINKS>
	</DATASET>
</DATASETS>